三五互聯(300051.SZ)延期回覆深交所問詢函
格隆匯2月24日丨三五互聯(300051.SZ)公佈,公司於2020年2月17日收到深圳證券交易所創業板公司管理部下發的《關於對廈門三五互聯科技股份有限公司的重組問詢函》(創業板許可類重組問詢函[2020]第7號)(“問詢函”),要求公司就所提問題做出書面説明、獨立財務顧問對部分問題發表明確的核查意見,並在2020年2月24日前報送有關説明材料。
因受新型冠狀病毒疫情防控工作的影響,公司無法在2020年2月24日前完成《問詢函》的回覆,已向深圳證券交易所申請延期回覆。公司預計將於2020年3月2日前對問詢函的問題予以回覆。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.